KRN7000

CAS : 158021-47-7

Ref. TR-K660000

Informations sur le produit

• Nom: KRN7000
• Synonymes: N-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide, Agl-582, Hexacosanamide, N-[(1S,2S,3R)-1-[(α-<span class="text-smallcaps">D</span>-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-, Hexacosanamide, N-[1-[(α-<span class="text-smallcaps">D</span>-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-, [1S-(1R*,2R*,3S*)]-, Krn-7000, Krn7000, N-[(1S,2S,3R)-1-[(α-<span class="text-smallcaps">D</span>-Galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]hexacosanamide, N-[1(S)-(alpha-D-Galactopyranosyloxymethyl)-2(S),3(R)-dihydroxyheptadecyl]hexacosanamide, N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}hexacosanamide, N-{(2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}hexacosanamide, alpha-Galactosylceramide
• CAS: 158021-47-7

Description

Stability Hygroscopic
Applications Galactosylceramides play an important roles in promoting the regulation of nerve cells, regulating protein kinase C activities and modulating the function of the hormone receptor. It has shown to have significant immunostimulatory and anti-umor activity in mice with liver metastasis of the Colon26 adenocarcinoma.
References Morita, M., et al.: J. Med. Chem., 38, 2176 (1995), Sakai, T., et al.: J. Med. Chem., 42, 1836 (1999),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 858.32
• Formule: C₅₀H₉₉NO₉
• Couleur/Forme: Neat
• InChI: InChI=1S/C50H99NO9/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-25-26-27-29-31-33-35-37-39-45(54)51-42(41-59-50-49(58)48(57)47(56)44(40-52)60-50)46(55)43(53)38-36-34-32-30-28-16-14-12-10-8-6-4-2/h42-44,46-50,52-53,55-58H,3-41H2,1-2H3,(H,51,54)/t42-,43+,44+,46-,47-,48-,49+,50-/m0/s1
• Code InChI: InChIKey=IQHAYPHXXSDEPN-BYSUZVQFSA-N
• SMILES: CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1[O])[C@H](O)[C@H](O)CCCCCCCCCCCCCC